

Publisher: Bentham Science Publishers
E-ISSN: 1875-6190|13|3|324-368
ISSN: 1570-159X
Source: Current Neuropharmacology, Vol.13, Iss.3, 2015-01, pp. : 324-368
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Potential of Levetiracetam in Mood Disorders: A Preliminary Review
By Muralidharan Anjana Bhagwagar Zubin
CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. :